Beam Therapeutics Inc.
BEAM
$31.58
-$0.17-0.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 83.17% | 79.02% | -188.11% | -178.05% | -186.79% |
| Total Depreciation and Amortization | 1.58% | 1.68% | 1.03% | 1.99% | 5.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -249.85% | -233.56% | -3.33% | 0.21% | 31.21% |
| Change in Net Operating Assets | -64.90% | -18.86% | 58.75% | 40.55% | 10.81% |
| Cash from Operations | -5.22% | 0.62% | -149.01% | -150.84% | -152.56% |
| Capital Expenditure | -47.43% | -67.07% | -48.27% | 32.56% | 68.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -64.94% | -154.87% | -153.67% | -197.05% | 432.78% |
| Cash from Investing | -74.49% | -165.64% | -166.04% | -218.56% | 1,702.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 84.73% | 83.13% |
| Issuance of Common Stock | -98.29% | 5,714.97% | 1,125.93% | 537.32% | 161.03% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -78.82% | 6,079.54% | 1,161.96% | 551.79% | 164.31% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -199.72% | 107.45% | -35.85% | -117.52% | 591.73% |